| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5162302 | Binding | Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis | Homo sapiens | 21 | ALA5154811 | cell-based format | Scientific Literature | |
| 2. | ALA5162303 | Binding | Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis | Homo sapiens | 22 | ALA5154811 | cell-based format | Scientific Literature | |
| 3. | ALA5162304 | Binding | Selectivity ratio of IC50 for wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells to IC50 for wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells | Homo sapiens | 21 | ALA5154811 | cell-based format | Scientific Literature | |
| 4. | ALA5162305 | Functional | Antiproliferative activity against human NCI-N87 cells assessed as inhibition of cell growth incubated for 72 hrs by Celltiter-Glo assay | Homo sapiens | 22 | ALA5154811 | cell-based format | Scientific Literature | |
| 5. | ALA5162306 | Functional | Antiproliferative activity against human BT-474 cells assessed as inhibition of cell growth incubated for 72 hrs by Celltiter-Glo assay | Homo sapiens | 22 | ALA5154811 | cell-based format | Scientific Literature | |
| 6. | ALA5162311 | Binding | Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis | Homo sapiens | 15 | ALA5154811 | cell-based format | Scientific Literature | |
| 7. | ALA5162312 | Binding | Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis | Homo sapiens | 15 | ALA5154811 | cell-based format | Scientific Literature | |
| 8. | ALA5162314 | ADME | Metabolic stability in human liver microsomes assessed as half life at 1 uM preincubated for 5 mins followed by NADPH addition by LC-MS/MS analysis | Homo sapiens | 6 | ALA5154811 | microsome format | Scientific Literature | |
| 9. | ALA5162315 | ADME | Metabolic stability in human liver microsomes assessed as intrinsic clearance at 1 uM preincubated for 5 mins followed by NADPH addition by LC-MS/MS analysis | Homo sapiens | 6 | ALA5154811 | microsome format | Scientific Literature | |
| 10. | ALA5162316 | ADME | Clearance in ICR mouse at 3 mg/kg, iv measured upto 1440 mins by LC/MS/MS analysis | Mus musculus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 11. | ALA5162317 | ADME | Clearance in Sprague-Dawley rat at 3 mg/kg, iv measured upto 1440 mins by LC/MS/MS analysis | Rattus norvegicus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 12. | ALA5162319 | ADME | Half life in ICR mouse at 3 mg/kg, iv measured upto 1440 mins by LC/MS/MS analysis | Mus musculus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 13. | ALA5162320 | ADME | Volume of distribution at steady state in ICR mouse at 3 mg/kg, iv measured upto 1440 mins by LC/MS/MS analysis | Mus musculus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 14. | ALA5162321 | ADME | Cmax in ICR mouse at 10 mg/kg, po measured upto 1440 mins by LC/MS/MS analysis | Mus musculus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 15. | ALA5162322 | ADME | Tmax in ICR mouse at 10 mg/kg, po measured upto 1440 mins by LC/MS/MS analysis | Mus musculus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 16. | ALA5162323 | ADME | AUC (0 to t) in ICR mouse at 10 mg/kg, po measured upto 1440 mins by LC/MS/MS analysis | Mus musculus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 17. | ALA5162324 | ADME | Half life in ICR mouse at 10 mg/kg, po measured upto 1440 mins by LC/MS/MS analysis | Mus musculus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 18. | ALA5162325 | ADME | Oral bioavailability in ICR mouse at 10 mg/kg measured upto 1440 mins by LC/MS/MS analysis | Mus musculus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 19. | ALA5162327 | ADME | Half life in Sprague-Dawley rat at 3 mg/kg, iv measured upto 1440 mins by LC/MS/MS analysis | Rattus norvegicus | 3 | ALA5154811 | organism-based format | Scientific Literature | |
| 20. | ALA5162328 | ADME | Volume of distribution at steady state in Sprague-Dawley rat at 3 mg/kg, iv measured upto 1440 mins by LC/MS/MS analysis | Rattus norvegicus | 3 | ALA5154811 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!